Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06XDS
|
||||
Former ID |
DIB005747
|
||||
Drug Name |
GSK-1070806
|
||||
Synonyms |
Anti-IL-18 monoclonal antibody (intravenous, inflammatory bowel disease), GSK
|
||||
Drug Type |
Antibody
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 2 | [523987] | ||
Company |
GlaxoSmithKline
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-18 | Target Info | [544164] | ||
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Interleukin signaling pathway | ||||
Toll receptor signaling pathway | |||||
Reactome | Interleukin-1 processing | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.